Centro Cardiologico Monzino IRCCS, Milan, Italy; Department of Biomedical Science for Health, University of Milan, Milan, Italy.
Internal Medicine Department, Fatebenefratelli Hospital, Milan, Italy.
Eur J Intern Med. 2024 May;123:132-137. doi: 10.1016/j.ejim.2024.01.024. Epub 2024 Jan 23.
The management of even large pericardial effusions in asymptomatic patients is still a matter of debate. Aim of the present study is to explore, in a multicenter setting, the rate of post-cardiac injury syndromes (PCIS) and pericardial effusion recurrence after pericardial effusion drainage procedure.
This is a multicenter international retrospective study including a consecutive cohort of patients diagnosed with large, chronic and idiopathic pericardial effusions, prospectively evaluated from January 2003 to December 2021 who underwent a clinically indicated pericardial drainage procedure. Two separate end-points were recorded: 1) recurrence of pericardial effusion after drainage without any sign of pericardial inflammation 2) occurrence of PCIS, defined as the new onset of pericarditis 1 to 6 weeks after pericardial intervention.
124 patients were enrolled (50 % female, mean age 64 years old). A mean follow-up of 29.6 ± 25.6 months was obtained in 110 patients (88 %). 110 patients were treated with pericardiocentesis (89 %), 25 with pleuro-pericardial windows (20 %), and 1 with pericardiectomy (1 %). PCIS occurred in 21 out of 124 patients followed for at least 6 weeks (16.9%). Recurrence of pericardial effusion after drainage without any sign of pericardial inflammation occurred in 68 out of 110 patients at a longer follow-up (61.8 %). At multivariate analysis only inflammatory cells in pericardial fluid was associated with PCIS and pericardiocentesis with pericardial effusion recurrency.
Our data support the need of caution with the use of pericardiocentesis in asymptomatic patients with large pericardial effusion as it is often associated with pericardial effusion recurrence. Of interest the presence of inflammatory cells in the pericardial fluid is associated with PCIS after pericardial drainage procedures.
即使在无症状患者中,大心包积液的处理仍然存在争议。本研究旨在多中心环境下探讨心脏损伤后综合征(PCIS)和心包积液引流后心包积液复发的发生率。
这是一项多中心国际回顾性研究,纳入了 2003 年 1 月至 2021 年 12 月期间连续诊断为大、慢性和特发性心包积液的患者,前瞻性评估并进行了临床指示的心包引流术。记录了两个单独的终点:1)引流后心包积液无任何心包炎迹象的复发;2)PCIS 的发生,定义为心包介入后 1 至 6 周新出现的心包炎。
共纳入 124 例患者(50%为女性,平均年龄 64 岁)。110 例患者(88%)获得了 29.6±25.6 个月的平均随访。110 例患者接受了心包穿刺术(89%),25 例患者接受了胸膜心包窗(20%),1 例患者接受了心包切除术(1%)。至少随访 6 周的 124 例患者中有 21 例发生 PCIS(16.9%)。在更长的随访时间内,110 例中有 68 例(61.8%)出现引流后心包积液无任何心包炎迹象的复发。多变量分析显示,心包积液中的炎症细胞与 PCIS 和心包穿刺术与心包积液复发有关。
我们的数据支持在无症状大心包积液患者中谨慎使用心包穿刺术,因为它通常与心包积液复发有关。有趣的是,心包引流术后心包积液中炎症细胞的存在与 PCIS 有关。